How GLP-1s Offer Real-World Heart Protection The evidence that GLP1-s reduce the risk of heart attack and stroke comes from large cardiovascular outcomes trials designed to measure what researchers call MACE, major adverse cardiovascular events
The American Diabetes Association suggests such approaches may improve body composition outcomes while maintaining the benefits of weight loss
Alluvis website is also still up and running as of 5 December, selling a retatrutide 40mg x2 Bundle (R&D Only) for 339.99
No clinical trial has answered this question definitively yet, but the mechanistic rationale is compelling
GLP-1 (Glucagon-Like Peptide-1) as distributed by Peptides Lab UK is not intended for, and must not be used for, human consumption, medical treatment, self-administration, veterinary applications, or any use outside of a controlled laboratory environment
95% CI -7.94, -0.25